Antibody-drug conjugates: paving the future of oncology clinical development
European Pharmaceutical Review
OCTOBER 26, 2023
Yet as the market continues to recognise the value of these treatments, especially with them having “clear benefits over current monotherapy and combination therapy options in cancer treatment”, it is unsurprising that GlobalData’s research predicted the ADC oncology therapy market will value more than $36 billion by 2029.
Let's personalize your content